Brian joined OrbiMed in 2022 as Director of Tax. He previously led tax at Sculptor Capital Management and was a senior manager at Rothstein Kass; he holds accounting and taxation degrees and is a CPA licensed in NYS.
Dina joined OrbiMed in 2023 as a Private Equity partner and has invested in healthcare private equity and venture capital since 2001. She previously worked at Omega Funds, NeoMed, 3i, and Index Ventures and holds a Ph.D. from Paris VI University.
Roy joined OrbiMed in 2016 as a Principal on the Private Equity team. He previously handled healthcare transactions at Bayer Health Care and held an M&A summer associate role at Life Technologies.
OrbiMed is a global investment firm that invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services companies.
OrbiMed’s privacy policy describes the personal information it collects through website visits or other interactions, how it uses and shares the information, and related rights.
